Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Brenzavvy discontinuation?
How long have hydroxyzine pamoate been on the market?
Pramlintide fda approval date?
Drugpatentwatch skyrizi biologic patent analysis?
Dabrafenib patent expiration?

Fda approval acalabrutinib date?

See the DrugPatentWatch profile for acalabrutinib

The FDA approved acalabrutinib (Calquence) for the first time on February 28, 2017, for adults with mantle cell lymphoma (MCL). If you need the approval dates for other indications (e.g., CLL/SLL or GVHD), I can provide those as well.



Other Questions About Acalabrutinib :

Acalabrutinib fda approval date calquence 2017? Acalabrutinib patent expiry? Acalabrutinib fda approval? Acalabrutinib 100 mg brands in india? Acalabrutinib fda approval date october 2017? Acalabrutinib fda approval date calquence? Acalabrutinib approval date fda?